Evidence map›Paper›PMID 38982067›Full record

ArticleNature communications2024

UPF1 plays critical roles in early B cell development.

Noriki Iwai, Kotaro Akaki, Fabian Hia, Wei Li, Masanori Yoshinaga, Takashi Mino, Osamu Takeuchi

Abstract read
In one paragraph

Article in Nature communications, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Noriki Iwai *Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0009-0005-6778-1125
Kotaro Akaki *Department of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0003-0059-3291
Fabian HiaDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.
Wei LiDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0009-0003-1419-9209
Masanori YoshinagaDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan.ORCID 0000-0001-5642-9752
Takashi MinoDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan. tmino@mfour.med.kyoto-u.ac.jp.ORCID 0000-0002-9562-008X
Osamu TakeuchiDepartment of Medical Chemistry, Graduate School of Medicine, Kyoto University, Kyoto, Japan. otake@mfour.med.kyoto-u.ac.jp.ORCID 0000-0002-1260-6232

Funding

Japan Agency for Medical Research and Development (AMED) JP20fk0108454Japan Agency for Medical Research and Development (AMED) JP20gm4010002Japan Agency for Medical Research and Development (AMED) JP21ae0121030MEXT | Japan Science and Technology Agency (JST) JPMJFR226EMEXT | Japan Science and Technology Agency (JST) JPMJMS2025MEXT | Japan Society for the Promotion of Science (JSPS) 18H05278MEXT | Japan Society for the Promotion of Science (JSPS) 221S0002MEXT | Japan Society for the Promotion of Science (JSPS) 23H00402MEXT | Japan Society for the Promotion of Science (JSPS) 24K02224MEXT | Japan Society for the Promotion of Science (JSPS) JPJSCCA20240006
6 · The paper itself

Abstract

The ATP-dependent RNA helicase UPF1 plays a crucial role in various mRNA degradation pathways, most importantly in nonsense-mediated mRNA decay (NMD). Here, we show that UPF1 is upregulated during the early stages of B cell development and is important for early B cell development in the bone marrow. B-cell-specific Upf1 deletion in mice severely impedes the early to late LPre-B cell transition, in which V

Indexed as

B-LymphocytesCell DifferentiationNonsense Mediated mRNA DecayRNA HelicasesAnimalsHumansImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsMiceMice, Inbred C57BLMice, KnockoutTrans-ActivatorsUnfolded Protein ResponseImmunoglobulin Heavy ChainsImmunoglobulin Light ChainsRent1 protein, mouseRNA HelicasesTrans-Activators

Identifiers

PMID38982067
PMCPMC11233602

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.